Health Investment Returns: Harnessing Health as...

By João L. Carapinha

November 18, 2025

Health as a Strategic Economic Imperative A country's enduring strength stems not solely from military or industrial resources but from the vitality and productivity of its populace. A recen...
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gr...
Navigating Targeted Therapy Access: Innovations and Challenges in High-Cost T...
Weight Loss: Advances in Hormone-Based Obesity Treatments
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Koselugo EU Approval: A Milestone in Treating Plexiform Neurofibromas for Adu...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
NICE Endorses Darolutamide Prostate Cancer Treatment for Improved Patient Access
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
Cabotegravir HIV Prevention: First Injectable PrEP Recommended for High-Risk ...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...